Human Papillomavirus (HPV) is a primarily sexually transmitted human pathogen linked with the formation of anogenital warts and several types of cancer including cervical cancer, oropharyngeal cancer, penile cancer, and anal cancer. HPV genotypes are divided into high-risk and low-risk in accordance with their potential for carcinogenesis. The most notable high-risk genotypes are HPV-16 and HPV-18. In this study we report on the PCR analysis results of the cervical smear results of 328 females, and 50 males who have presented to a tertiary care university hospital in the port city of İzmir, Türkiye between August 2019 and August 2022. HPV-DNA positivity percentage was determined as 25.3% (96/378). 5 of 378 patients were HPV-18 positive (age range 31–80) whereas 27 patients were HPV-16 positive (age range 29–66). 64 patients were positive for other high-risk HPV types (age range 27–56). The positivity for HPV-16, HPV-18 and other high-risk HPV types were determined as 7.14%, 1.3% and 16.9% respectively. Our results demonstrate a 25.3% (96/378) positivity among tested patients moreover, out of 96 positive cases at least 32 are vaccine preventable. This study indicates the need for higher coverage of HPV vaccination in Western Türkiye.
Peker BO, Müderris T, Gül Yurtsever S, Kaya S. Servikal fırça örneklerinde insan papilloma virüs prevalansı ve genotip dağılımı; üç yıllık analiz [Human papillomavirus prevalence and genotype distribution in Servical swab samples: outcomes of a three-year analysis]. Turk Mikrobiyol Cemiy Derg 2022; 52(3): 168–174. Turkish.
Vos RA, Pasmans H, Tymchenko L, Janga-Jansen A, Baboe-Kalpoe S, Hulshof K, et al. High seroprevalence of multiple high-risk human papillomavirus types among the general population of Bonaire, St. Eustatius and Saba, Caribbean Netherlands. Vaccine 2020; 38(13): 2816–2826. Available from: https://doi.org/10.1016/j.vaccine.2020.02.017.
Zhang J, Zhang D, Yang Z, Wang X, Wang D. The role of human papillomavirus genotyping for detecting high-grade intraepithelial neoplasia or cancer in HPV-positive women with normal cytology: a study from a hospital in northeastern China. BMC Cancer 2020; 20(1): 443. Published 2020 May 19. https://doi.org/10.1186/s12885-020-06935-w.
World Health Organization. Cervical cancer. https://www.who.int/news-room/fact-sheets/detail/cervical-cancerPublished Feb 22, 2022. Accessed Oct 24, 2022.
Choi YJ, Park JS. Clinical significance of human papillomavirus genotyping. J Gynecol Oncol 2016; 27(2): e21. https://doi.org/10.3802/jgo.2016.27.e21.
Öztürker O, Sönmez G. Endometrium ve Serviks Kanserlerinde Görüntüleme [Imaging in endometrial and cervical cancer]. Trd Sem 2015; 3: 1–11. https://doi.org/10.5152/trs.2015.158Accessed Oct 23, 2022. Turkish.
Usubütün A, Alemany L, Küçükali T, Ayhan A, Yüce K, Sanjosé Silvia, et al. Human papillomavirus types in invasive cervical cancer specimens from Turkey. Int J Gynecol Pathol 2009; 28(6): 541–548. Available from: https://doi.org/10.1097/PGP.0b013e3181aaba0d.
Hancer VS, Buyukdogan M, Bylykbashi I, Oksuz B, Acar M. Prevalence of human papilloma virus types in Turkish and Albanian women. J Cytol 2018; 35(4): 252–254. https://doi.org/10.4103/JOC.JOC_162_17.
Campari C, Fedato C, Iossa A, Petrelli A, Zorzi M, Anghinoni E, et al. Cervical cancer screening in immigrant women in Italy: a survey on participation, cytology and histology results. Eur J Cancer Prev 2016; 25(4): 321–328. JSTOR, https://www.jstor.org/stable/48504705. Accessed 25 Oct. 2022.
Alan M, Oruç MA, Yılmaz N, Aytaç H, Sanci M, Alan Y. Evaluation of HPV incidence and cervical smear results in Syrian refugees. Ankara Med J 2020; 20(1): 1–10.
Bruni L, Albero G, Serrano B, Mena M, Collado JJ, Gómez D, et al. ICO/IARC information Centre on HPV and cancer (HPV Information Centre). Human papillomavirus and related diseases in the world. Summary report. https://hpvcentre.net/statistics/reports/XWX.pdf. Published Oct 22, 2021. Accesssed Oct 24, 2022.
Duran AÇ, Alev E, Sayıner A. Determination of human papilloma viruses DNA and genotypes in genital samples with PCR. J Clin Anal Med 2017; 8: 302–306. Available from: https://doi.org/10.4328/JCAM.4881.
Sahin HG, Kolusari A, Guducuoglu H. Prevalence of high risk human papillomavirus (HPV) infection and abnormal cervical cytology and knowledge about HPV vaccine in Eastern Turkey. Eur J Gynaecol Oncol 2017; 38(2): 241–244.
Özmen E, Altoparlak Ü, Uyanık MH, Gülen A. Servikal örneklerde yüksek riskli human papillomavirüs genotiplerinin dağılımı ve prevalansı [The distribution and prevelance of high-risk Human Papillomavirus genotypes in cervical samples]. FLORA 2020; 25(3): 325–331. Turkish.
Kan Ö, Görkem Ü, Barış A, Koçak Ö, Toğrul C, Yıldırım E. Evaluation of the frequency of Human Papillomavirus (HPV) in women admitted to cancer early diagnosis and screening training centers (KETEM) and analysis of HPV genotypes. Türk Hijyen ve Deneysel Biyoloji Dergisi 2019; 76(2): 163–168.
Kazancı F, Koçak A, Colak M, Erdem Ö, Bozdayi G. HPV tip 66’yı Olası yüksek riskli Grupta Değerlendirmeli miyiz? Ankara Gazi Üniversitesi’ndeki HPV tip 66’nın prevalansı, Klinik ve histopatolojik Değerlendirmesi [Should we evaluate HPV-66 as a high-risk group member? A prevalence, clinical and histopathological evaluation in Ankara Gazi university]. Gazi Medical Journal 2021; 32: 98–103 Turkish.
Alacam S, Bakir A. Human papillomavirus prevalence and genotype distribution in cervical swab samples in Istanbul, Turkey. J Infect Dev Ctries 2021; 15(8): 1190–1196. https://doi.org/10.3855/jidc.14663.
Argyri E, Tsimplaki E, Papatheodorou D, Daskalopoulou D, Panotopoulou E. Recent trends in HPV infection and type distribution in Greece. Anticancer Res 2018; 38(5): 3079–3084. https://doi.org/10.21873/anticanres.12565.
Fappani C, Bianchi S, Panatto D, Petrelli F, Colzani D, Scuri S, et al. HPV type-specific prevalence a decade after the implementation of the vaccination program: results from a Pilot study. Vaccines 2021; 9: 336. Available from: https://doi.org/10.3390/vaccines9040336.
Salavatiha Z, Farahmand M, Shoja Z, Jalilvand S. A meta-analysis of human papillomavirus prevalence and types among Iranian women with normal cervical cytology, premalignant lesions, and cervical cancer. J Med Virol 2021; 93(8): 4647–4658. https://doi.org/10.1002/jmv.26928.
Al Moustafa AE, Ghabreau L, Akil N, Rastam S, Alachkar A, Yasmeen A. High-risk HPVs and human carcinomas in the Syrian population. Front Oncol 2014; 4: 68. Published 2014 Apr 2. https://doi.org/10.3389/fonc.2014.00068.
Maver PJ, Poljak M. Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans. Clin Microbiol Infect 2020; 26(5): 579–583.
Arbyn M, Simon M, Peeters E, Xu L, Meijer CJLM, Berkhof J, et al. 2020 List of human papillomavirus assays suitable for primary cervical cancer screening. Clin Microbiol Infect 2021; 27(8): 1083–1095.